Companies: 10,795·Total market cap: $144.5T
Rein Therapeutics Inc.

Rein Therapeutics Inc.

RNTXNASDAQHealthcare● Active
$0.95
+$0.01(+0.59%)
Market Cap$26521833
P/E Ratio—
52W High$2.18
52W Low$0.915
Overview

Rein Therapeutics Inc.（RNTX）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

rntx · 股价预测 · 2 位分析师（近3月）· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Buy

2 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 50.0%

12 个月目标价

High

$6.00

Consensus

$6.00

+532.4% upside

Low

$6.00

Median: $6 · Last Close: $0.95

Rein Therapeutics Inc.（RNTX）的分析师共识为 Buy，基于过去 3 个月内 2 位华尔街分析师的评级。RNTX 的 12 个月平均目标价为 $6.00，相对当前价 $0.95 代表 +532.4% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

Bear

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$0.90↓ 4.88%

1-day model range: $0.89–$0.92. Peak: $0.92 (-4.88%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$0-50.0%
2028$0-62.5%
2029$0-67.2%
2030$0-69.2%
2031—-70.2%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)39.2Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · RNTX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.99SELL
MA 10$1.04SELL
MA 20$1.05SELL
MA 50$1.29SELL
MA 100$1.27SELL
MA 200$1.29SELL
Current $RNTX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.99SELL
EMA 10$1.02SELL
EMA 20$1.08SELL
EMA 50$1.19SELL
EMA 100$1.25SELL
EMA 200$1.36SELL
Current $RNTX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2026-06-01
Maintains
Buy→Buy
Brookline Capital2026-01-21
Downgrade ↓
Buy→Hold
Brookline Capital2025-08-19
Downgrade ↓
Buy→Hold

Wall Street analysts have recently issued updated ratings on Rein Therapeutics Inc. (RNTX) stock. Of the recent 3 rating actions, 0 were upgrades and 2 were downgrades. 2 analysts currently cover RNTX.

分析师推荐趋势

Buy ratings0 → 1↑ +1
Hold ratings1 → 0↓ 1
Sell ratings0 → 0

RNTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$70M

Revenue Next Year

$128M

↑ 83.0% YoY

EPS This Year

$-0.53

EPS Next Year

$-0.50

↓ 5.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast RNTX EPS of $-0.53 for the current fiscal year, based on estimates from 1 analysts. The RNTX revenue forecast is $70M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

RNTX 股价预测由两类独立数据源支撑：来自 2 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。RNTX 的共识目标价为 $6.00（+532.4% 上行空间），分析师共识为 Buy。

RNTX 的短期预测（明日）为 $0.90（-4.88%）。 RNTX 对 2027 年的股价预测均值为 $0。 RNTX 对 2030 年的预测区间为 $0–$0。

Rein Therapeutics Inc. 在 NASDAQ 上市，代码 RNTX。RNTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 50% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

RNTX 预测 · 8 个问题

根据 2 位华尔街分析师，RNTX 的 12 个月平均目标价为 $6.00，最高 $6.00、最低 $6.00。若有图表，中位目标价可在上方查看。相对当前价 $0.95，隐含约 +532.4% 的上行空间。

RNTX 目标价RNTX 分析师目标价RNTX 12个月目标价目标价 RNTX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.